Liquidia Corporation
LQDANASDAQHealthcare● Active
$63.90
+$2.05(+3.31%)
Market Cap$5.7B
P/E Ratio—
52W High$66.775
52W Low$11.85
Liquidia Corporation (LQDA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LQDA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
$0.52
Est. $0.34 · +52.9%
Revenue
$0.13B
Est. $0.12B · +11.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
LQDA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | $0.79 | — | — | — | $0.17B | — |
| ▲ Q2 FY2026 | May 11, 2026 | $0.34 | $0.52 | +52.9% | $0.13B | $0.12B | +11.2% |
| ▲ Q1 FY2026 | Mar 5, 2026 | $0.08 | $0.15 | +87.5% | $0.09B | $0.09B | +3.9% |
| ▲ Q4 FY2025 | Nov 3, 2025 | -$0.45 | -$0.04 | +91.1% | $0.05B | $0.08B | -32.7% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.43 | -$0.49 | -13.9% | $0.01B | $0.01B | -38.2% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.42 | -$0.45 | -7.1% | $0.00B | $0.00B | -25.0% |
| ▼ Q1 FY2025 | Mar 19, 2025 | -$0.38 | -$0.46 | -21.1% | $0.00B | $0.00B | -12.0% |
| — Q4 FY2024 | Nov 13, 2024 | -$0.37 | -$0.37 | +0.0% | $0.00B | $0.00B | -4.0% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
$0.79
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
$0.52
EPS Est.
$0.34
EPS Surpr.
+52.9%
Revenue
$0.13B
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
$0.15
EPS Est.
$0.08
EPS Surpr.
+87.5%
Revenue
$0.09B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
-$0.04
EPS Est.
-$0.45
EPS Surpr.
+91.1%
Revenue
$0.05B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.49
EPS Est.
-$0.43
EPS Surpr.
-13.9%
Revenue
$0.01B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.45
EPS Est.
-$0.42
EPS Surpr.
-7.1%
Revenue
$0.00B
Q1 FY2025
Mar 19, 2025Miss
EPS Actual
-$0.46
EPS Est.
-$0.38
EPS Surpr.
-21.1%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.37
EPS Est.
-$0.37
EPS Surpr.
+0.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.30 | $1.80 | $2.09 | 2 |
| Q3 FY2027 | $1.20 | $1.65 | $1.92 | 1 |
| Q2 FY2027 | $1.08 | $1.49 | $1.73 | 1 |
| Q1 FY2027 | $0.95 | $1.31 | $1.52 | 2 |
| Q4 FY2026 | $0.81 | $1.12 | $1.30 | 2 |
| Q3 FY2026 | $0.52 | $0.94 | $1.46 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.3B | $0.4B | $0.4B | 3 |
| Q3 FY2027 | $0.2B | $0.3B | $0.4B | 2 |
| Q2 FY2027 | $0.2B | $0.3B | $0.3B | 2 |
| Q1 FY2027 | $0.2B | $0.3B | $0.3B | 3 |
| Q4 FY2026 | $0.2B | $0.2B | $0.3B | 3 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +52.9% | $42.30 | $53.13 | +25.60% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +87.5% | $34.38 | $34.52 | +0.41% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +91.1% | $24.36 | $25.22 | +3.53% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -13.9% | $21.20 | $24.10 | +13.68% |
| ▼ Q2 FY2025 | May 8, 2025 | -7.1% | $15.53 | $15.35 | -1.16% |
| ▼ Q1 FY2025 | Mar 19, 2025 | -21.1% | $14.74 | $14.92 | +1.22% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +0.0% | $10.63 | $10.27 | -3.39% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -5.7% | $11.06 | $10.68 | -3.44% |
Q2 FY2026+25.60%
Report Date
May 11, 2026
EPS Beat/Miss
+52.9%
Price Before
$42.30
Price After
$53.13
Q1 FY2026+0.41%
Report Date
Mar 5, 2026
EPS Beat/Miss
+87.5%
Price Before
$34.38
Price After
$34.52
Q4 FY2025+3.53%
Report Date
Nov 3, 2025
EPS Beat/Miss
+91.1%
Price Before
$24.36
Price After
$25.22
Q3 FY2025+13.68%
Report Date
Aug 12, 2025
EPS Beat/Miss
-13.9%
Price Before
$21.20
Price After
$24.10
Q2 FY2025-1.16%
Report Date
May 8, 2025
EPS Beat/Miss
-7.1%
Price Before
$15.53
Price After
$15.35
Q1 FY2025+1.22%
Report Date
Mar 19, 2025
EPS Beat/Miss
-21.1%
Price Before
$14.74
Price After
$14.92
Q4 FY2024-3.39%
Report Date
Nov 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$10.63
Price After
$10.27
Q3 FY2024-3.44%
Report Date
Aug 7, 2024
EPS Beat/Miss
-5.7%
Price Before
$11.06
Price After
$10.68
Avg Beat Reaction+6.54%
Avg Miss Reaction+2.58%
Beat Rate4 / 8 quarters
Largest Move+25.60% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LQDA ends December
Liquidia Corporation (LQDA) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $0.52 — beating the analyst consensus of $0.34 by +52.9%. LQDA has beaten EPS estimates for 3 consecutive quarters. The next LQDA earnings date is expected around September 1, 2026.
Each quarter, investors track LQDA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LQDA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LQDA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LQDA earnings · 5 questionsLiquidia Corporation's next earnings report is expected around September 1, 2026. LQDA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LQDA historically reports after market close (AMC).
LQDA earnings datewhen is LQDA earningsLQDA next earnings datewhen does LQDA report earningsLQDA earnings calendar
▸ Source: FMP · Liquidia Corporation SEC filings · US GAAP · Liquidia Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026